CSL · 3 days ago
Associate Director Market Access, Partner Business
CSL is seeking an Associate Director Market Access, Partner Business to enable patient access to innovative therapies through strategic pricing and market access solutions. This role involves collaborating with regional teams and external partners to navigate complex healthcare systems and drive sustainable growth.
BiotechnologyHealth CareHealth DiagnosticsMedical
Responsibilities
Maximize Patient Access: Develop and implement strategies to ensure timely, equitable access to key products across all partner markets
Value and Access: Design and execute innovative pricing and reimbursement approaches tailored to local market needs, supporting business partners in building compelling value propositions for new launches and product lifecycle management
Partner Enablement: Equip business partners with the tools, insights, and support needed to optimize portfolio performance and navigate local access challenges
Cross-Functional Collaboration: Navigate effectively within the matrix, and act as a key connector between regional teams, International Brand Teams, Global Market Access and external partners to ensure alignment with global objectives and successful execution of access and pricing strategies
Market Intelligence: Monitor local healthcare environments, policy developments, and payer trends to identify opportunities and risks, sharing actionable insights across the partner network
Budget Management: Oversee budget allocation for the assigned portfolio, ensuring resources are used efficiently to support strategic objectives
Performance Measurement: Define and track key performance indicators to assess the impact of access and pricing initiatives
Qualification
Required
Degree in Life Sciences, Pharmacy, Health Economics, or Business
Minimum 8-10 years in pricing, market access, or related functions in healthcare
Willingness to travel internationally as required
Preferred
MBA or advanced degree preferred
Experience in emerging or diverse markets is a plus
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase